In addition to a radiologic and clinical response, this patient displayed statistically significant decreases in GRM1, AKT, and pro-apoptotic protein BIM in analyses of paired tumor tissue, supporting target engagement and activity. This evidence concerns the gene BCL2L11 and neoplasm.